Your session is about to expire
← Back to Search
Cannabinoid
Ethanol + Cannabinoid Effects on DUI (THC-ETOH Trial)
Phase 1
Waitlist Available
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Males or females 21 to 55 years of age (extremes included)
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up +40 mins after start of alcohol and thc infusion
Awards & highlights
THC-ETOH Trial Summary
This trial will look at the effects of ethanol and cannabinoids on driving ability and related cognition.
Who is the study for?
This trial is for men and women aged 21 to 55 who have used cannabis and alcohol at least once. They must be able to understand and agree to the study's terms. Pregnant individuals, those who've never consumed alcohol or cannabis, or people with hearing problems cannot participate.Check my eligibility
What is being tested?
The study aims to assess how ethanol (alcohol) and cannabinoids (like THC from cannabis) affect simulated driving performance and cognitive functions related to driving. Participants will receive either a placebo, active THC, or active ethanol during the trial.See study design
What are the potential side effects?
Possible side effects may include impaired motor skills, altered perception, dizziness, delayed reaction times, difficulty concentrating or remembering things which are common effects of alcohol and THC.
THC-ETOH Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 21 and 55 years old.
THC-ETOH Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ +40 mins after start of alcohol and thc infusion
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~+40 mins after start of alcohol and thc infusion
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Road Tracking Error
Secondary outcome measures
Biphasic Alcohol Effects Scale (BAES)
Cognitive Test Battery
Number of Drinks Scale
+3 moreTHC-ETOH Trial Design
4Treatment groups
Experimental Treatment
Placebo Group
Group I: Placebo THC and Active EthanolExperimental Treatment2 Interventions
Group II: Active THC and Placebo EthanolExperimental Treatment2 Interventions
Group III: Active THC and Active EthanolExperimental Treatment2 Interventions
Group IV: Placebo THC and Placebo EthanolPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Placebo
1995
Completed Phase 3
~2670
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Yale UniversityLead Sponsor
1,837 Previous Clinical Trials
2,728,373 Total Patients Enrolled
82 Trials studying Alcoholism
10,226 Patients Enrolled for Alcoholism
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have hearing problems.I am between 21 and 55 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Placebo THC and Active Ethanol
- Group 2: Placebo THC and Placebo Ethanol
- Group 3: Active THC and Placebo Ethanol
- Group 4: Active THC and Active Ethanol
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger